GoodRx vs Trinity Meds
GoodRx and Trinity Meds both sell tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between GoodRx and Trinity Meds, price alone will not settle it. Both prescribe tirzepatide, so moving from one to the other would not change your drug. Trinity Meds leads our six-part score, 7.5 to 6.9.
GoodRx vs Trinity Meds price
GoodRx and Trinity Meds start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Tirzepatide is cheaper at Trinity Meds ($199 a month vs $299 a month).
Medications and formats
Both sell tirzepatide; only GoodRx lists orforglipron; only Trinity Meds lists semaglutide.
On format, GoodRx prices brand-name pens, while Trinity Meds prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
GoodRx lists 50 states, and Trinity Meds does not publish where it ships.
Pricing
GoodRx
Trinity Meds
All-inclusive flat rate, same price every dose; as low as $129/mo on the 6-month plan
All-inclusive flat rate (reg $299); as low as $149/mo on the 12-month plan
What each price covers
Trinity Meds' price also covers the clinician visit, the medication itself and shipping, which GoodRx does not claim.
GoodRx does not say what its price includes.
Trinity Meds is silent on lab work and coaching.
That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.
GoodRx
Inclusions not disclosed.
Trinity Meds
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Trinity Meds scores 7.5 and GoodRx 6.9 out of 10.
GoodRx is stronger on accessibility (10.0 vs 5.0).
Trinity Meds is stronger on value (6.6 vs 5.0), user experience (8.0 vs 5.0), trust & safety (6.5 vs 6.0) and support (7.0 vs 5.0).
Effectiveness is within half a point.
GoodRx
6.9/10
Trinity Meds
7.5/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GoodRx nor Trinity Meds has an FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Trinity Meds |
|---|---|---|
| Starting Price | $149/mo | $149/mo |
| Features | 6 features | 6 features |
| States Available | 50 | Not disclosed |
| Compounded | — | — |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | ✓ Yes |
| FDA Warning Letters | None | None |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Trinity Meds
Trinity Meds charges an all-inclusive flat rate of $149/month for compounded semaglutide and $199/month for tirzepatide, the same price at every dose, with free shipping and no insurance; multi-month plans drop the price further. The program is aimed at military women, spouses and veterans. You take a short online assessment and a CareValidate Health clinician reviews eligibility and prescribes if appropriate. The named entity is Trinity Meds Inc, but it publishes no terms page, names no pharmacies, and lists no states.
Read our full Trinity Meds review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Trinity Meds
What we like
- Semaglutide costs $149 a month, 19% below the $184 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $199 a month, 20% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Trinity Meds
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Trinity Meds wins this one, 7.5 to 6.9, above all for compounded semaglutide at $149/month. GoodRx fits better if oral orforglipron alongside the injectables is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Trinity Meds if…
You want compounded semaglutide at $149/month and an opening price near $149 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →GoodRx vs Trinity Meds: FAQ
Close alternatives to GoodRx and Trinity Meds
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- Trinity Meds vs altRX
- Trinity Meds vs PlushCare
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.